- Details
- Medical Oncologist and co-leader of the Women's Bladder Cancer Program at John Hopkins, Jean Hoffman-Censits joins Alicia Morgans to speak about bladder cancer in women and the initiatives and importance of the Women's Bladder Cancer Program. In many cases, there are significant delays in diagnosing bladder cancer in women. Dr. Hoffman-Censits discusses the continuous narrative of the delay in dia...
|
- Details
- Oliver Sartor joins Alicia Morgans to highlight the recently published PROfound Trial. A phase III trial of Lynparza (olaparib) in men with metastatic castration-resistant prostate cancer (mCRPC) who have a homologous recombination repair gene mutation and have progressed on prior treatment with new hormonal agent treatments. The PROfound trial was published in the New England Journal of Medicine...
|
- Details
- Recorded Date: April 24, 2020 Zachary Klaassen and Christopher Wallis join Alicia Morgans to discuss the management guide released by European Urology on how to best optimize the care of patients with GU malignancies during the COVID-19 pandemic. In this Journal Club, Dr. Klaassen and Dr. Wallis assess the impact of delayed treatment of bladder cancer. Biographies: Zachary Klaassen, MD, MSc, Urolo...
|
- Details
- Michael Hofman, from the Peter MacCallum Cancer Centre in Melbourne, Australia joins Charles Ryan to go "beyond the VISION Trial" discussing ongoing clinical trials with lutetium, for example, TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603) where results are...
|
- Details
- Jamie Landman and Monty Pal are joined by a multidisciplinary panel of experts to discuss the correlation between diet, nutrition, and lifestyle on solitary kidney function and cardiovascular health. Biographies: Kamyar Kalantar-Zadeh, MD, MPH, Ph.D., Chief and Professor, Department of Medicine’s Division of Nephrology & Hypertension, UC Irvine Connie Rhee, MD, Assistant Professor, Division of Nep...
|
- Details
- Recorded Date: April 28, 2020 Joining Alicia Morgans is Pedro Barata from Tulane University in New Orleans, Louisiana to discuss the difficulties of balancing the risk of COVID-19 with the risk of delaying systematic therapies in one of the United State’s hotspots. Dr. Barata distinguishes differences in managing prostate, kidney, and bladder cancer care in this current healthcare setting. Biograp...
|
- Details
- The large registry, PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data (PROCEED) (NCT01306890), evaluated sipuleucel-T immunotherapy for asymptomatic/minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Oliver Sartor, the primary author joins Alicia Morgans to provide an update on the PROCEED registry aiming to understand outcomes for Afr...
|
- Details
- Charles Ryan is joined by the leadership of the Prostate Cancer Clinical Trials Consortium, a group that has developed innumerable trials and therapies for advanced prostate cancer. The Prostate Cancer Clinical Trials Consortium (PCCTC) was initiated in 2005 by the Prostate Cancer Foundation (PCF) and the U.S. Department of Defense (DOD) Prostate Cancer Research Program (PCRP) in response to criti...
|
- Details
- Recorded Date: April 24, 2020 Zachary Klaassen and Christopher Wallis join Alicia Morgans to discuss the management guidance released by European Urology on how to best optimize the care of patients with UTUC malignancies during the COVID-19 pandemic. In this Journal Club, Dr. Klaassen and Dr. Wallis assess the impact of delaying treatment in patients with upper tract urothelial carcinoma and disc...
|
- Details
- Karen Knudsen joins Alicia Morgans to discuss the motivation, vision, and drivers behind this year's GU ASCO 2020 meeting "in pursuit of patient-centered care". Along with other planning committee organization, Karen Knudsen was responsible for and played a key role in the formulation and direction of this year's meeting. She highlights the multidisciplinary considerations and new advancements the...
|
